Mesalazine
- Generic Name
- Mesalazine
- Brand Names
- Apriso, Asacol, Canasa, Delzicol, Lialda, Mezavant, Pentasa, Rowasa, Salofalk, Zaldyon
- Drug Type
- Small Molecule
- Chemical Formula
- C7H7NO3
- CAS Number
- 89-57-6
- Unique Ingredient Identifier
- 4Q81I59GXC
- Background
An anti-inflammatory agent, structurally related to the salicylates and non-steroidal anti-inflammatory drugs like acetylsalicylic acid, which is active in inflammatory bowel disease . Although demonstrably effective in treating and maintaining remission for ulcerative colitis, mesalazine has historically faced a number of issues regarding its lack of stabil...
- Indication
适用于溃疡性结肠炎和克罗恩病（Crohn病）。
- Associated Conditions
- Acute Ulcerative Colitis, Crohn's Disease Relapse, Crohn's Ileocolitis, Mild to Moderate Ulcerative Colitis, Proctitis, Proctitis, Ulcerative, Proctosigmoiditis, Ulcerative Colitis in Remission, Mild Ulcerative Colitis, Mild to moderate distal ulcerative colitis, Moderate Ulcerative colitis
- Associated Therapies
- -
Efficacy and Safety of SPD476 in Maintaining Remission in Patients With Ulcerative Colitis
- First Posted Date
- 2005-09-09
- Last Posted Date
- 2021-06-14
- Lead Sponsor
- Shire
- Target Recruit Count
- 829
- Registration Number
- NCT00151892
- Locations
- 🇨🇱
Hospital San Juan de Dios, Santiago, Chile
🇮🇳Sanjay Gandhi Post Graduate Institute of Medical Sciences, Lucknow, India
🇲🇽Instituto Nacional de Ciencias médicas y Nutrición Salvador Zubirán, Mexico DF, Mexico
Effect of an Anti-Inflammatory Drug on Gut Mucosa in HIV Infected Patients
- Conditions
- First Posted Date
- 2003-09-30
- Last Posted Date
- 2007-05-25
- Target Recruit Count
- 14
- Registration Number
- NCT00069498
- Locations
- 🇺🇸
David Geffen School of Medicine at UCLA, Los Angeles, California, United States
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.